Brazil
Substance Comunicação is a communication agency specializing in healthcare and wellness. Founded in 2009, the agency prides itself on its strategic approach, creativity, and agility, all aimed at maintaining healthy partnerships. With a 360-degree mindset, it engages diverse audiences and ensures the delivery of messages effectively. The agency's client portfolio includes influential names such as Abbvie, Aché, Amgen, Baxter, Janssen-Cilag, Johnson & Johnson, AstraZeneca, Eurofarma, Momenta, MSD, and Leo Pharma.
With a focus on advertising and health and wellness industries, Substance Comunicação has positioned itself as a versatile and results-driven agency. Despite the absence of disclosed recent investment details and investors, the agency's established presence in the healthcare sector, notable client collaborations, and its commitment to delivering impactful communication solutions make it an interesting prospect for potential venture capital considerations.
